These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31299466)

  • 1. Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis.
    Ghang B; Lee J; Chan Kwon O; Ahn SM; Oh JS; Hong S; Kim YG; Yoo B; Jeong WS; Kim J; Lee CK
    Respir Med; 2019 Aug; 155():43-48. PubMed ID: 31299466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study.
    Song MJ; Lee SH; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Kim SY
    BMC Pulm Med; 2021 May; 21(1):145. PubMed ID: 33941141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
    Yoshimura K; Kono M; Enomoto Y; Nishimoto K; Oyama Y; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Sumikawa H; Johkoh T; Colby TV; Sugimura H; Suda T
    Respir Med; 2018 Apr; 137():167-175. PubMed ID: 29605201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody status is not associated with change in lung function or survival in patients with idiopathic pulmonary fibrosis.
    Goobie GC; Ford-Sahibzada CA; Fritzler MJ; Johannson KA; Fell CD
    Respir Med; 2019 Jul; 153():85-90. PubMed ID: 31176275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study.
    Kim MJ; Nathan SD; Kim HH; Kim HC
    Ther Adv Respir Dis; 2024; 18():17534666241275329. PubMed ID: 39175212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis.
    Hosoda C; Baba T; Hagiwara E; Ito H; Matsuo N; Kitamura H; Iwasawa T; Okudela K; Takemura T; Ogura T
    Respirology; 2016 Jul; 21(5):920-6. PubMed ID: 26994375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients.
    Sambataro G; Sambataro D; Torrisi SE; Vancheri A; Colaci M; Pavone M; Pignataro F; Del Papa N; Palmucci S; Vancheri C
    Respir Med; 2019 Apr; 150():154-160. PubMed ID: 30961944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
    Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
    BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis.
    Ando M; Miyazaki E; Ishii T; Mukai Y; Yamasue M; Fujisaki H; Ito T; Nureki S; Kumamoto T
    Respir Med; 2013 Apr; 107(4):608-15. PubMed ID: 23434037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
    Donahoe M; Valentine VG; Chien N; Gibson KF; Raval JS; Saul M; Xue J; Zhang Y; Duncan SR
    PLoS One; 2015; 10(6):e0127771. PubMed ID: 26083430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
    Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K
    BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbation in antineutrophil cytoplasmic antibody-associated interstitial lung disease: Clinical features and risk factors.
    Otsuka J; Yoshizawa S; Ikematsu Y; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022 Nov; 203():106992. PubMed ID: 36252462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of progression of idiopathic pulmonary fibrosis to connective tissue disease: a long-term observational study in 527 patients.
    Ghang B; Nam SH; Lee J; Lim DH; Ahn SM; Oh JS; Hong S; Kim YG; Yoo B; Kim J; Lee CK
    Clin Rheumatol; 2021 Jun; 40(6):2447-2456. PubMed ID: 33754221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis.
    Kamiya H; Panlaqui OM
    BMJ Open; 2019 May; 9(5):e027849. PubMed ID: 31147365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study.
    Tomassetti S; Ravaglia C; Puglisi S; Wells AU; Ryu JH; Bosi M; Dubini A; Piciucchi S; Girelli F; Parronchi P; Lavorini F; Rosi E; Luzzi V; Cerinic MM; Poletti V
    Front Med (Lausanne); 2023; 10():1087485. PubMed ID: 36873871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.